Cellular and molecular aspects of familial hypertrophic cardiomyopathy caused by mutations in the cardiac troponin I gene

By Gomes Aldrin V.   Potter James D.  

Molecular and Cellular Biochemistry, Vol. 263, Iss. 1, 2004-08 ,pp. : 99-114

Springer Publishing Company

Access to resources Recommend Favorite

Effects of Two Hypertrophic Cardiomyopathy Mutations in alpha-Tropomyosin, Asp175Asn and Glu180Gly, on Ca 2+ Regulation of Thin Filament Motility

By Bing W.   Redwood C.S.   Purcell I.F.   Esposito G.   Watkins H.   Marston S.B.  

Biochemical and Biophysical Research Communications, Vol. 236, Iss. 3, 1997-07 ,pp. : 760-764

Elsevier

Access to resources Recommend Favorite

A low prevalence of MYH7 / MYBPC3 mutations among Familial Hypertrophic Cardiomyopathy patients in India

By Bashyam Murali  

Molecular and Cellular Biochemistry, Vol. 360, Iss. 1-2, 2012-01 ,pp. : 373-382

Springer Publishing Company

Access to resources Recommend Favorite

Calpain-1-dependent degradation of troponin I mutants found in familial hypertrophic cardiomyopathy

By Barta J.   Tóth A.   Jaquet K.   Redlich A.   Édes I.   Papp Z.  

Molecular and Cellular Biochemistry, Vol. 251, Iss. 1-2, 2003-09 ,pp. : 83-88

Springer Publishing Company

Access to resources Recommend Favorite

Multiple gene mutations, not the type of mutation, are the modifier of left ventricle hypertrophy in patients with hypertrophic cardiomyopathy

By Zou Yubao  

Molecular Biology Reports, Vol. 40, Iss. 6, 2013-06 ,pp. : 3969-3976

Springer Publishing Company

Access to resources Recommend Favorite